Huawei’s recent launch of the Mate 70 series has sparked significant discussion, but unfortunately, it has not ignited the same level of excitement as its predecessors. Launched to great anticipation, … Read More
Ocado Group, a prominent player in the online supermarket industry, has recently announced that its partner, Morrisons, will be gradually discontinuing deliveries from the Erith robotic warehouse located in London. … Read More
In a recent announcement that has excited cricket fans, England’s dynamic all-rounder Liam Livingstone expressed his clear preference to join the Royal Challengers Bangalore (RCB) instead of the Punjab Kings … Read More
Italian authorities have successfully dismantled a vast international TV piracy network that boasted over 22 million users worldwide. The operation, dubbed “Blackout,” involved a coordinated effort between the Italian Police … Read More
Robbie Williams, one of the most recognizable pop icons of the modern era, is preparing to unveil his latest documentary, Better Man, which delves deep into his personal and professional … Read More
Tech giant Google has taken legal action by appealing to the U.S. Court of Appeals for the Ninth Circuit against a jury’s recent decision that deemed the company guilty of … Read More
T-Mobile, one of the leading wireless carriers in the U.S., has acknowledged a recent cyberattack but reassured its customers that no sensitive personal information was compromised. The company made it … Read More
China is gearing up to significantly enhance its global positioning system (GPS) capabilities with the upcoming launch of its next-generation Beidou network. State broadcaster CCTV reported on Thursday that the … Read More
The U.S. Federal Trade Commission (FTC) has launched a comprehensive antitrust investigation into Microsoft, targeting its software licensing, cloud computing, cybersecurity, and artificial intelligence (AI) practices. This move marks the … Read More
Amgen, a leading biotechnology company, announced today that its investigational weight-loss drug, MariTide (maridebart cafraglutide), did not meet its primary endpoint in a Phase 2 clinical trial. The news sent … Read More
